• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外囊泡在慢性栓塞后肺动脉高压中的作用:来自实验动物模型和患者的数据。

Role of Extracellular Vesicles in Chronic Post-Embolic Pulmonary Hypertension: Data from an Experimental Animal Model and Patients.

作者信息

Mendoza-Zambrano Elva, Sánchez-López Verónica, Gómez-Rodríguez Belén, García-Lunar Inés, Pereda-Arnau Daniel, Jara-Palomares Luis, Elías-Hernández Teresa, García-Álvarez Ana, Otero-Candelera Remedios

机构信息

Medical Surgical Unit of Respiratory Diseases, Virgen del Rocio University Hospital, 41013 Seville, Spain.

Institute of Biomedicine of Seville (IBiS) Virgen del Rocio University Hospital/CSIC/University of Seville, 41013 Seville, Spain.

出版信息

Biomedicines. 2025 Jun 18;13(6):1499. doi: 10.3390/biomedicines13061499.

DOI:10.3390/biomedicines13061499
PMID:40564220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12191311/
Abstract

: The pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH) involves a multifaceted interplay of factors, including incomplete thrombus resolution, endothelial dysfunction, and vascular remodeling. Recent studies have highlighted the role of extracellular vesicles (EVs) in vascular diseases, suggesting their potential involvement in CTEPH progression. This study aims to investigate the role of EVs from various cellular sources in the development of CTEPH. : An experimental study was conducted using 11 male three-month-old Large-White pigs. The EVs of endothelial origin (EEVs; CD146+), leukocyte-derived EVs (LEVs; CD45+, CD44+), and consistent with mesenchymal-origin EVs (CD90+, CD105+) were quantified. Measurements were taken at baseline, after the first embolization, and prior to each subsequent weekly embolization. Embolizations were repeated until chronic pulmonary hypertension (PH) was generated. Based on these findings, a clinical case-control study was performed involving nine patients previously diagnosed with CTEPH and 18 patients with pulmonary embolism who did not develop CTEPH after two years of follow-up. : The experimental study, consistent with the mesenchymal-origin EVs, exhibited a progressive decrease below baseline levels; LEVs decreased after PH was established, while EEVs remained elevated throughout the study. Subsequently, in the clinical case-control study, CD45+ LEVs emerged as a significant association of CTEPH, with an odds ratio (OR) of 21.25 (95% CI: 1.91-236.00; = 0.013). : Inflammation involving LEVs and EEVs plays a crucial role in sustaining the vascular alterations leading to pulmonary vasculature remodeling in CTEPH.

摘要

慢性血栓栓塞性肺动脉高压(CTEPH)的发病机制涉及多种因素的相互作用,包括血栓溶解不完全、内皮功能障碍和血管重塑。最近的研究强调了细胞外囊泡(EVs)在血管疾病中的作用,表明它们可能参与CTEPH的进展。本研究旨在探讨来自不同细胞来源的EVs在CTEPH发生发展中的作用。

使用11只3个月大的雄性大白猪进行了一项实验研究。对内皮来源的EVs(EEVs;CD146+)、白细胞衍生的EVs(LEVs;CD45+、CD44+)以及与间充质来源一致的EVs(CD90+、CD105+)进行了定量分析。在基线、首次栓塞后以及随后每周栓塞前进行测量。重复栓塞直至产生慢性肺动脉高压(PH)。基于这些发现,进行了一项临床病例对照研究,纳入了9例先前诊断为CTEPH的患者和18例肺栓塞患者,后者在两年随访后未发生CTEPH。

实验研究中,与间充质来源一致的EVs呈现出逐渐下降至基线水平以下的趋势;PH形成后LEVs下降,而EEVs在整个研究过程中一直升高。随后,在临床病例对照研究中,CD45+ LEVs成为CTEPH的显著相关因素,比值比(OR)为21.25(95% CI:1.91 - 236.00;P = 0.013)。

涉及LEVs和EEVs的炎症在维持导致CTEPH肺血管重塑的血管改变中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fd0/12191311/13721e494bfc/biomedicines-13-01499-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fd0/12191311/dfd18d9686bc/biomedicines-13-01499-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fd0/12191311/b602522da932/biomedicines-13-01499-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fd0/12191311/e0acb0aab9dc/biomedicines-13-01499-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fd0/12191311/13721e494bfc/biomedicines-13-01499-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fd0/12191311/dfd18d9686bc/biomedicines-13-01499-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fd0/12191311/b602522da932/biomedicines-13-01499-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fd0/12191311/e0acb0aab9dc/biomedicines-13-01499-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fd0/12191311/13721e494bfc/biomedicines-13-01499-g004.jpg

相似文献

1
Role of Extracellular Vesicles in Chronic Post-Embolic Pulmonary Hypertension: Data from an Experimental Animal Model and Patients.细胞外囊泡在慢性栓塞后肺动脉高压中的作用:来自实验动物模型和患者的数据。
Biomedicines. 2025 Jun 18;13(6):1499. doi: 10.3390/biomedicines13061499.
2
Guanylate cyclase stimulators for pulmonary hypertension.用于肺动脉高压的鸟苷酸环化酶刺激剂。
Cochrane Database Syst Rev. 2016 Aug 2;2016(8):CD011205. doi: 10.1002/14651858.CD011205.pub2.
3
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
4
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
8
Medical Therapy Versus Balloon Angioplasty for CTEPH: A Systematic Review and Meta-Analysis.慢性血栓栓塞性肺动脉高压的药物治疗与球囊血管成形术:系统评价与荟萃分析
Heart Lung Circ. 2018 Jan;27(1):89-98. doi: 10.1016/j.hlc.2017.01.016. Epub 2017 Mar 1.
9
Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis.波生坦治疗慢性血栓栓塞性肺动脉高压:系统评价和荟萃分析的结果。
Thromb Res. 2010 Jul;126(1):e51-6. doi: 10.1016/j.thromres.2010.01.007. Epub 2010 Feb 21.
10
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.

本文引用的文献

1
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.塞拉替尼治疗成人肺动脉高压(TORREY):一项随机、双盲、安慰剂对照的 2 期临床试验。
Lancet Respir Med. 2024 Jul;12(7):523-534. doi: 10.1016/S2213-2600(24)00072-9. Epub 2024 May 2.
2
The Use of Microencapsulated Autologous Thrombi for Modelling Chronic Thromboembolic Pulmonary Hypertension in Rats.微囊化自体血栓在大鼠慢性血栓栓塞性肺动脉高压模型中的应用
Bull Exp Biol Med. 2023 Sep;175(5):616-619. doi: 10.1007/s10517-023-05912-0. Epub 2023 Oct 19.
3
Microvesicles and inflammatory markers in an animal model of chronic postcapillary pulmonary hypertension.
慢性毛细血管后肺动脉高压动物模型中的微泡与炎症标志物
Int J Med Sci. 2023 Aug 28;20(10):1336-1338. doi: 10.7150/ijms.84924. eCollection 2023.
4
Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management.慢性血栓栓塞性肺动脉高压:实现多模式管理的潜力。
Lancet Respir Med. 2023 Sep;11(9):836-850. doi: 10.1016/S2213-2600(23)00292-8. Epub 2023 Aug 14.
5
Inhibition of JAK1,2 Prevents Fibrotic Remodeling of Pulmonary Vascular Bed and Improves Outcomes in the Rat Model of Chronic Thromboembolic Pulmonary Hypertension.抑制 JAK1、2 可预防肺血管床的纤维化重塑,并改善慢性血栓栓塞性肺动脉高压大鼠模型的结局。
Int J Mol Sci. 2022 Dec 9;23(24):15646. doi: 10.3390/ijms232415646.
6
Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Pulmonary Hypertension: A Comprehensive Review of Preclinical Studies.间质干细胞衍生的细胞外囊泡治疗肺动脉高压:临床前研究的综合综述。
J Interv Cardiol. 2022 Nov 4;2022:5451947. doi: 10.1155/2022/5451947. eCollection 2022.
7
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
8
An explorative metabolomic analysis of the endothelium in pulmonary hypertension.肺动脉高压内皮的探索性代谢组学分析。
Sci Rep. 2022 Aug 2;12(1):13284. doi: 10.1038/s41598-022-17374-x.
9
Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension.肺栓塞和慢性血栓栓塞性肺动脉高压的啮齿动物模型。
Heliyon. 2022 Feb 24;8(3):e09014. doi: 10.1016/j.heliyon.2022.e09014. eCollection 2022 Mar.
10
Magnolol Attenuates Right Ventricular Hypertrophy and Fibrosis in Hypoxia-Induced Pulmonary Arterial Hypertensive Rats Through Inhibition of the JAK2/STAT3 Signaling Pathway.厚朴酚通过抑制JAK2/STAT3信号通路减轻缺氧诱导的肺动脉高压大鼠的右心室肥厚和纤维化。
Front Pharmacol. 2021 Oct 26;12:755077. doi: 10.3389/fphar.2021.755077. eCollection 2021.